TMSP(SH:600671)2014-09-29 16:00Financial Performance - The company reported a basic earnings per share of CNY 0.02 for 2013, a significant improvement from a loss of CNY 0.73 in 2012[16]. - The weighted average return on equity was 2.63% in 2013, recovering from a negative 71.88% in 2012[16]. - Non-recurring gains amounted to CNY 5,394,596.17 in 2013, compared to a loss of CNY 1,154,041.07 in 2012[16]. - The company reported a net profit of -2,108,420.84 RMB for 2013, with no cash dividends distributed due to negative retained earnings[40]. - The company achieved total operating revenue of 281.47 million RMB, a year-on-year increase of 22.87%[17]. - The net profit attributable to shareholders was 2.11 million RMB, marking a turnaround from a loss in the previous year[18]. - The main business revenue reached 261.71 million RMB, with a year-on-year growth of 16.84%, exceeding the annual plan by 5.18%[18]. - The company reported a comprehensive income of ¥2,503,024.05, a turnaround from a comprehensive loss of ¥87,164,044.50 in the previous period[111]. - The total revenue for the year is reported at 8.4 billion, reflecting a growth of 3.2% year-over-year[124]. - The company reported a decrease in net profit margin, reflecting challenges in maintaining profitability[131]. Dividends and Shareholder Information - The company did not declare any dividends for 2013 due to negative net profit and accumulated undistributed profits[5]. - The total number of shareholders at the end of the reporting period was 9,409, an increase from 8,310 prior to the annual report disclosure[59]. - The top shareholder, Tianjin Changhui Investment Management Partnership, holds 8.20% of shares, totaling 9,983,684 shares[59]. - The total number of shares outstanding is 121,778,885, with 99.95% being freely tradable shares[55]. - The company has no internal employee shares as of the end of the reporting period[56]. Assets and Liabilities - The total assets at the end of the period were 324.58 million RMB, reflecting a 9.68% increase from the previous year[17]. - Total liabilities increased to CNY 226,408,405.61, compared to CNY 200,252,157.92 at the beginning of the year, reflecting an increase of about 13.1%[103]. - The company's equity attributable to shareholders increased to CNY 81,280,078.41 from CNY 79,171,657.57, an increase of approximately 2.7%[105]. - The total current liabilities amounted to CNY 196,808,405.61, a decrease from CNY 199,452,157.92, indicating a reduction of about 0.8%[103]. Operational Efficiency and Management - The company plans to enhance sales efforts and optimize management processes to improve operational efficiency[34]. - A focus on human resource management will be implemented to ensure adequate staffing and performance evaluation[35]. - The company aims to innovate marketing strategies and strengthen communication with health product companies to resolve sales issues[34]. - The company has implemented safety production management practices, emphasizing the principle of "safety first, prevention foremost" to protect employee health and safety[38]. - The company is focusing on improving operational efficiency to counteract the decline in profits[131]. Research and Development - The company is focusing on technological innovation and product development, with plans to expedite the approval of its medicinal products[38]. - Research and development expenses have increased by 5% to support new product innovations[125]. - The company plans to invest in research and development to innovate and stay competitive in the market[132]. Market Expansion and Future Strategies - The company plans to focus on market expansion and new product development to sustain growth momentum in the upcoming periods[110]. - The company is exploring potential mergers and acquisitions to enhance its market position[125]. - The company aims to achieve a revenue growth target of 20% for the next fiscal year, driven by new product launches and market expansion strategies[129]. - The company plans to expand its market presence by launching two new products in the upcoming year, targeting a 15% increase in market share[129]. Corporate Governance - The company has established a modern corporate governance structure, ensuring equal rights for all shareholders, particularly minority shareholders[86]. - The board of directors held 7 meetings during the year, with all members attending and no absenteeism reported[90]. - The company has implemented a comprehensive internal control system to ensure compliance with laws and regulations, enhancing operational efficiency and effectiveness[93]. - The company has made efforts to improve information disclosure practices, ensuring timely and accurate communication with shareholders[87]. Environmental and Social Responsibility - The company is committed to environmental protection, having upgraded wastewater treatment facilities to meet pollution discharge standards[43]. - The company has a workforce of 703 employees, contributing to social employment pressures and maintaining a harmonious labor relationship[44]. Financial Management and Taxation - The company benefits from a reduced corporate income tax rate of 15% due to its subsidiary being recognized as a high-tech enterprise from January 1, 2011, to December 31, 2013[184]. - The company enjoys a preferential income tax rate of 15% as a high-tech enterprise from January 1, 2013, to December 31, 2015[185]. - The company has implemented strategies to reduce tax burdens through various tax incentives and exemptions provided by local tax authorities[185].